- HOME
- Investor Relations
- [Financial Highlights] Segment and Regional Information
Consolidated Financial Results by Business Segment
Net Sales
| Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Total | |
|---|---|---|---|---|---|
| '18/3 | 300,117 | 60,080 | 35,170 | 29 | 395,397 |
| '19/3 | 327,359 | 63,482 | 35,526 | 31 | 426,399 |
| '20/3 | 335,767 | 70,357 | 36,217 | 174 | 442,516 |
| '21/3 | 347,648 | 68,564 | 38,655 | 691 | 455,559 |
* Reporting Segment was changed as a result of the corporate reorganization.
The segment information is presented as if the reorganization had been conducted at the beginning of the fiscal year 2018.
Operating Income
| Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Adjustment | Total | |
|---|---|---|---|---|---|---|
| '18/3 | 36,522 | 11,428 | 367 | 75 | -21,306 | 27,088 |
| '19/3 | 36,722 | 10,662 | 778 | 146 | -24,482 | 23,827 |
| '20/3 | 36,249 | 13,196 | 675 | 176 | -23,877 | 26,420 |
| '21/3 | 39,415 | 10,072 | 1,992 | 376 | -24,228 | 27,627 |
Net Sales by Region
| Japan | America | Europe | Asia | Total | |||||
|---|---|---|---|---|---|---|---|---|---|
| Net sales | Proportion | Net sales | Proportion | Net sales | Proportion | Net sales | Proportion | Net sales | |
| '18/3 | 241,750 | 61.2% | 56,704 | 14.3% | 46,389 | 11.7% | 50,553 | 12.8% | 395,397 |
| '19/3 | 260,967 | 61.2% | 59,836 | 14.0% | 51,042 | 12.0% | 54,552 | 12.8% | 426,399 |
| '20/3 | 267,708 | 60.5% | 64,153 | 14.5% | 50,801 | 11.5% | 59,853 | 13.5% | 442,516 |
| '21/3 | 270,543 | 59.4％ | 71,572 | 15.7％ | 52,167 | 11.5％ | 61,275 | 13.5％ | 455,559 |
Proportion of Net Sales by Region (2021/3)
